GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cathay Biotech Inc (SHSE:688065) » Definitions » Total Assets

Cathay Biotech (SHSE:688065) Total Assets : ¥18,618 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cathay Biotech Total Assets?

Cathay Biotech's Total Assets for the quarter that ended in Mar. 2024 was ¥18,618 Mil.

During the past 12 months, Cathay Biotech's average Total Assets Growth Rate was 12.50% per year. During the past 3 years, the average Total Assets Growth Rate was 38.20% per year. During the past 5 years, the average Total Assets Growth Rate was 27.00% per year.

During the past 8 years, Cathay Biotech's highest 3-Year average Total Assets Growth Rate was 53.80%. The lowest was 13.20%. And the median was 34.30%.

Total Assets is connected with ROA %. Cathay Biotech's annualized ROA % for the quarter that ended in Mar. 2024 was 2.25%. Total Assets is also linked to Revenue through Asset Turnover. Cathay Biotech's Asset Turnover for the quarter that ended in Mar. 2024 was 0.04.


Cathay Biotech Total Assets Historical Data

The historical data trend for Cathay Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cathay Biotech Total Assets Chart

Cathay Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial 5,981.78 12,135.15 16,185.15 17,827.28 18,833.37

Cathay Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18,199.55 18,492.90 18,797.75 18,833.37 18,617.74

Cathay Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cathay Biotech's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=14773.11+4060.263
=18,833

Cathay Biotech's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=14863.9+3753.844
=18,618

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cathay Biotech  (SHSE:688065) Total Assets Explanation

Total Assets is connected with ROA %.

Cathay Biotech's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=421.036/( (18833.373+18617.744)/ 2 )
=421.036/18725.5585
=2.25 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cathay Biotech's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=684.522/( (18833.373+18617.744)/ 2 )
=684.522/18725.5585
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cathay Biotech Total Assets Related Terms

Thank you for viewing the detailed overview of Cathay Biotech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Cathay Biotech (SHSE:688065) Business Description

Traded in Other Exchanges
N/A
Address
1690 Cailun Road, 4th Floor, Building 5, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Cathay Biotech Inc is engaged in production of revolutionary products, including bio-based polyamide,bio-based DN5 (1,5-pentanediamine), long chain dibasic acids (LCDA) and biobutanol. The company's commercial development platform focuses on research of molecular biology, fermentation process engineering, polymer material. Its products include Dibasic Acids, Pentamethylene Diamine, and Bio-based Polyamide.

Cathay Biotech (SHSE:688065) Headlines

No Headlines